Streamlining the Transition from RUO to GMP

  • <<
  • >>

BlueskyReddit

The move from research-grade to GMP-grade reagents is where inconsistent sourcing, performance variability, and last-minute substitutions turn into failed tech transfers and regulatory delays. This white paper breaks down the RUO, RUO+, GMP, and cGMP manufacturing grades, sets ISO 9001 against ISO 13485, and explains where 21 CFR 210-211 and 820 apply and why reagents consumed as ancillary materials generally fall outside them. It covers why starting in a facility operating an ISO 13485 certified QMS avoids requalifying a partner later, and closes with a stage-by-stage table of reagent considerations across process development, scale-up, and tech transfer.

Access Now

    Please fill out the information below to access the selected content. If you are already registered, and this information will be filled out for you.
  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • By submitting this form, you consent to Cell & Gene Therapy Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.